Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O75027
UPID:
ABCB7_HUMAN
Alternative names:
ATP-binding cassette sub-family B member 7, mitochondrial; ATP-binding cassette transporter 7
Alternative UPACC:
O75027; G3XAC4; O75345; Q5VWY7; Q5VWY8; Q9BRE1; Q9UND1; Q9UP01
Background:
The Iron-sulfur clusters transporter ABCB7, mitochondrial, plays a pivotal role in cellular iron homeostasis and mitochondrial function. It exports glutathione-coordinated iron-sulfur clusters from the mitochondria to the cytosol, facilitating the assembly of cytosolic iron-sulfur cluster-containing proteins. This process is crucial for heme biosynthesis and the regulation of cellular reactive oxygen species levels, particularly in cardiomyocytes.
Therapeutic significance:
Linked to Anemia, sideroblastic, spinocerebellar ataxia, ABCB7's dysfunction underscores its therapeutic potential. Understanding the role of Iron-sulfur clusters transporter ABCB7 could open doors to potential therapeutic strategies for treating related disorders, emphasizing the importance of targeted research in this area.